Coronary Artery Perforation: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
{{SI}}
{{CMG}}<br/>
'''Associate Editors-In-Chief:''' Xin Yang, M.D.; Duane Pinto, M.D.; Brian C. Bigelow, M.D.
==Background==
Coronary perforation occurs when a [[dissection]] or an [[intimal]] tear is so severe that it extends outward sufficiently to completely penetrate the arterial wall.  It is an uncommon complication of [[PCI|coronary intervention]], with an incidence of 0.19%-0.58%<ref name="pmid16996872">{{cite journal |author=Javaid A, Buch AN, Satler LF, ''et al.'' |title=Management and outcomes of coronary artery perforation during percutaneous coronary intervention |journal=Am. J. Cardiol. |volume=98 |issue=7 |pages=911–4 |year=2006 |month=October |pmid=16996872 |doi=10.1016/j.amjcard.2006.04.032 |url=}}</ref><ref name="pmid14691432">{{cite journal |author=Fasseas P, Orford JL, Panetta CJ, ''et al.'' |title=Incidence, correlates, management, and clinical outcome of coronary perforation: analysis of 16,298 procedures |journal=Am. Heart J. |volume=147 |issue=1 |pages=140–5 |year=2004 |month=January |pmid=14691432 |doi= |url=}}</ref><ref name="pmid11246236">{{cite journal |author=Dippel EJ, Kereiakes DJ, Tramuta DA, ''et al.'' |title=Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: an algorithm for percutaneous management |journal=Catheter Cardiovasc Interv |volume=52 |issue=3 |pages=279–86 |year=2001 |month=March |pmid=11246236 |doi=10.1002/ccd.1065 |url=}}</ref>, as noted among various studies.  However, it is associated with significant [[morbidity]] and [[mortality]].  One study found a 12.6% incidence of [[acute myocardial infarction]], 11.6% incidence of [[cardiac tamponade]] and a mortality rate of 7.4%<ref name="pmid14691432">{{cite journal |author=Fasseas P, Orford JL, Panetta CJ, ''et al.'' |title=Incidence, correlates, management, and clinical outcome of coronary perforation: analysis of 16,298 procedures |journal=Am. Heart J. |volume=147 |issue=1 |pages=140–5 |year=2004 |month=January |pmid=14691432 |doi= |url=}}</ref>.
Associations with coronary perforation include:
* Balloon to artery ratio > 1.1
* Use of [[debulking]] procedure 
* Complex [[coronary anatomy]] (i.e. [[calcified]] lesion, [[chronic total occlusion]], [[tortuosity]] of the vessel and ostial lesion)
* Stiff and [[hydrophilic]] wires
==Classification==
==Classification==
The Ellis Classification<ref name="pmid7994814">{{cite journal |author=Ellis SG, Ajluni S, Arnold AZ, ''et al.'' |title=Increased coronary perforation in the new device era. Incidence, classification, management, and outcome |journal=Circulation |volume=90 |issue=6 |pages=2725–30 |year=1994 |month=December |pmid=7994814 |doi= |url=}}</ref> categorizes coronary artery perforations based on their [[angiographic]] appearance in the following manner:
The Ellis Classification<ref name="pmid7994814">{{cite journal |author=Ellis SG, Ajluni S, Arnold AZ, ''et al.'' |title=Increased coronary perforation in the new device era. Incidence, classification, management, and outcome |journal=Circulation |volume=90 |issue=6 |pages=2725–30 |year=1994 |month=December |pmid=7994814 |doi= |url=}}</ref> categorizes coronary artery perforations based on their [[angiographic]] appearance in the following manner:
Line 20: Line 6:
* '''Type III "cavity spilling" (CS)''' - Refers to Type III perforations with contrast spilling directly into either the [[left ventricle]], [[coronary sinus]], or another anatomic circulatory chamber
* '''Type III "cavity spilling" (CS)''' - Refers to Type III perforations with contrast spilling directly into either the [[left ventricle]], [[coronary sinus]], or another anatomic circulatory chamber


The Ellis Classification was evaluated as a predictor of certain outcomes and as a basis for management. Stratification of the outcomes by perforation type is summarized as follows<ref name="pmid7994814">{{cite journal |author=Ellis SG, Ajluni S, Arnold AZ, ''et al.'' |title=Increased coronary perforation in the new device era. Incidence, classification, management, and outcome |journal=Circulation |volume=90 |issue=6 |pages=2725–30 |year=1994 |month=December |pmid=7994814 |doi= |url=}}</ref>:
 
* '''Type I''' - No deaths or [[myocardial infarction]], [[tamponade]] incidence 8%
* '''Type II''' - No deaths, [[myocardial infarction]] incidence 14%, [[tamponade]] incidence 13%
* '''Type III''' - Mortality incidence 19%, cardiac [[tamponade]] incidence 63%, the need for urgent [[bypass surgery]] 63%
* '''Type III "cavity spilling" (CS)''' - No deaths, [[myocardial infarction]] or [[tamponade]], but sample limited in size


==Goals of Treatment==
==Goals of Treatment==
There are several goals involved in treating perforations.  Prevention of complications such as [[tamponade]], [[MI|myocardial infarction (MI)]] and death is critical.  It is important to maintain [[hemodynamic]] stability.  Should tamponade occur, it is important to detect and treat it immediately.  Additionally, a goal of treatment is to decrease the need for emergent [[bypass surgery]].
There are several goals involved in treating perforations.  Prevention of complications such as [[tamponade]], [[MI|myocardial infarction (MI)]] and death is critical.  It is important to maintain [[hemodynamic]] stability.  Should tamponade occur, it is important to detect and treat it immediately.  Additionally, a goal of treatment is to decrease the need for emergent [[bypass surgery]].


==Treatment==
Many different treatment options exist.  Depending on the severity of the perforation, up to 90% can be treated successfully without surgery.


The reversal of [[anticoagulation]] can be accomplished with [[Protamine]] if the patient is on [[heparin]] (guided by [[activated clotting time]]), or through [[platelet]] [[transfusions]] (4-10 units) if the patient was given [[abciximab]] or [[thienopyridine]]. 


Prolonged balloon inflation may be another treatment option.  Immediate occlusion of the perforated vessel at the perforation site for 10 minutes at 2-4 [[atms]] is recommended. If there is continued evidence of perforation, use perfusion balloons (if available) to allow for prolonged inflation without inducing myocardial [[ischemia]].  
Prolonged balloon inflation may be another treatment option.  Immediate occlusion of the perforated vessel at the perforation site for 10 minutes at 2-4 [[atms]] is recommended. If there is continued evidence of perforation, use perfusion balloons (if available) to allow for prolonged inflation without inducing myocardial [[ischemia]].  

Revision as of 13:08, 25 October 2011

Classification

The Ellis Classification[1] categorizes coronary artery perforations based on their angiographic appearance in the following manner:

  • Type I - Extraluminal crater without extravasation
  • Type II - Epicardial fat or myocardial blush without contrast jet extravasation
  • Type III - Extravasation through frank (> 1 mm) perforation
  • Type III "cavity spilling" (CS) - Refers to Type III perforations with contrast spilling directly into either the left ventricle, coronary sinus, or another anatomic circulatory chamber


Goals of Treatment

There are several goals involved in treating perforations. Prevention of complications such as tamponade, myocardial infarction (MI) and death is critical. It is important to maintain hemodynamic stability. Should tamponade occur, it is important to detect and treat it immediately. Additionally, a goal of treatment is to decrease the need for emergent bypass surgery.


Prolonged balloon inflation may be another treatment option. Immediate occlusion of the perforated vessel at the perforation site for 10 minutes at 2-4 atms is recommended. If there is continued evidence of perforation, use perfusion balloons (if available) to allow for prolonged inflation without inducing myocardial ischemia.

Other measures can be considered after prolong balloon inflation is initiated. Coil embolization and intra aortic balloon pump (IABP) counterpulsation are two options.

Additionally, polytetrafluoroethylene (PTFE) covered stents (Jomed stent)[2] can seal the perforation site. However, the stent is bulky and can be difficult to deploy. To decrease the timing between deflation of balloon and deployment of the stent, bilateral groin access with the two guide catheters approach should be considered.

Adjunctive hemodynamic monitoring and support is another option for treatment. Hemodynamic assessment with right heart pressure monitoring should be considered, but it is important to pay particular attention to a sudden rise in right atrial filling pressures. Also, it is important to monitor heart borders on fluoroscopy to detect signs of tamponade, as signified by a lack of movement of the heart borders.

Urgent echocardiography is an option to evaluate for pericardial effusion and tamponade physiology. Immediate notification of the cardiothoracic surgical team is important.

Advantages of Each Choice

Prolonged balloon inflations can be performed rapidly. However, patients may not tolerate balloon inflations because of the development of ischemia, arrhythmias, or hemodynamic instability. Therefore, perfusion balloon use may be optimal if it is available.

PTFE coated stent placement can rapidly and effectively close vessel wall defects, obviating open surgical procedures.

Surgical repair offers the advantage of visualizing difficult-to-identify perforations. Cardiopulmonary bypass may be needed to hemodynamically stabilize patients with perforations.

Coil embolization is suitable for small side branch perforations, but it will lead to tissue infarction and may not be available in all catheterization laboratories.

Making a Selection

Initial management of perforations should always begin with prolonged balloon inflation.

Once prolonged balloon inflation is attempted, other options may be explored. PTFE coated stents have now become more readily available and are deployed more frequently. They can be used for most coronary perforations, but small, excessively angulated or tortuous vessels may not be amenable to them.

Coil embolization is suited for small vessels, distal locations, arteries that supply limited viable myocardium, or situations where surgery is contraindicated.

Surgical closure is necessary for perforations that demonstrate continued bleeding despite minimal invasive therapy, refractory ischemia, or recurrent hemorrhage.

Pericardiocentesis is indicated to prevent overt cardiac tamponade for all patients who accumulate pericardial fluid as evidenced by increasing right atrial pressure.

Is Treatment Working?

There are several signs that indicate whether treatment is failing. Incomplete closure is signified by persistent dye extravasation, while pericardial fluid collection and impending cardiac tamponade is signified by increasing right atrial pressure. Peristent fluid accumulation or pericardial drain output (>24 h) should prompt surgical repair.

Serial echocardiography should be performed q 6-12h.

References

  1. Ellis SG, Ajluni S, Arnold AZ; et al. (1994). "Increased coronary perforation in the new device era. Incidence, classification, management, and outcome". Circulation. 90 (6): 2725–30. PMID 7994814. Unknown parameter |month= ignored (help)
  2. Fineschi M, Gori T, Sinicropi G, Bravi A (2004). "Polytetrafluoroethylene (PTFE) covered stents for the treatment of coronary artery aneurysms". Heart. 90 (5): 490. PMC 1768192. PMID 15084537. Unknown parameter |month= ignored (help)


Template:SIB

Template:WikiDoc Sources Template:Mdr